Upstate Active Clinical Trials Seeking Participants
Study title
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
IRB number
5241
What is the purpose of the study?
To determine whether the results of three different blood tests, taken together, can predict in advance which patients are likely to develop severe late reactions to radiation, so that treatment options for these patients can be adjusted accordingly.
Who is eligible?
Women who underwent lumpectomy followed by external beam radiation therapy between the ages of 45-65 as treatment for breast cancer, at least 2.5 years prior to study entry.
What is involved if I participate?
- How long is the study?
one visit - Is transportation provided or reimbursed?
Yes - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
Each potential study subject will be examined by her own radiation oncologist, who will explain the study at a regularly scheduled follow-up visit. Assessment will be made as to whether each subject displays minimal, intermediate, or severe radiation reactions. After informed consent is obtained, a second radiation oncologist will perform a physical exam to assess the degree of radiation reaction; and 1-2 tablespoons of blood will be drawn. This is the extent of the subjects participation. Thereafter, the blood obtained from the subject will be analyzed and the results correlated with the results of the physical exams by the radiation oncologists, to determine whether the blood test results can accurately identify which of the study subjects exhibited minimal, intermediate, and severe radiation reactions.
Who is the doctor administering the study?
Peter J. Hahn, PhD
Where will the study take place?
University Hospital & Hill Radiation Oncology
Over what time period is the study scheduled to run?
July 2005 - Ongoing
Who can I contact for more information?
- Name: Dena Martin
- Phone: 315-464-5262
- Email: martind@upstate.edu
- Fax: 315-464-5943
If you are interested in this trial, please contact the study coordinator or investigator noted above.
